RE: BAIT AND SWITCH.27 Dec 2019 10:25
It is worth far more now it has FDA approval.....,but their other stuff is regarded as having even more potential following their review
And the sale price will be based on projections of sales contained in the Information Memorandum(not sales to date) ,as supported by evidence of interest from potential partners ,and evidence from the clinical trials they were running with clinics to restrospectively confirm Stonechecker's prediction capabilities..
I would expect the process of sale to be quick as we are basically selling an asset ,there is no history of a company to look into for past liabilities hidden away ,ie no extensive due diligence of past compliance with eg tax returns .
I draw great comfort that managment has some serious skin in the game,and they have a good track record .
Happy New Year